Belle Health review

The costs at a glance

The supply term belongs beside the monthly price

Belle advertises compounded semaglutide from $109 per month and tirzepatide from $179. Those are useful starting references, but the pricing page says a longer supply lowers the monthly cost. I would not read the smallest figure as a promise that a single month can be bought for that amount. Ask for the supply length, full amount collected today and next renewal amount together. The general pricing page also contains a $119 compounded starting reference, different from the semaglutide product page. That discrepancy is a reason to confirm the selected offer before payment, rather than silently choose the most attractive number. For more context, see our complete GLP-1 cost guide.

The two weekly injection options are different purchases

The public treatment pages describe compounded semaglutide and compounded tirzepatide, both administered weekly under a clinician’s direction. They are not interchangeable line items merely because the care package looks similar. I would ask which formulation is actually proposed, what supply quantity accompanies the quote and whether the price continues as the prescribed dose changes. Belle advertises flat pricing across doses, which is useful for budgeting when it applies to the selected plan. Keep the exact product and term on the written quote so a lower starting price does not stand in for a comparison of different medications.

Support is more than a prescription decision

Belle’s pricing page includes clinician review, ongoing adjustments, nurse support and group dietitian sessions. That combination may appeal to someone who wants practical help between refill decisions. I would distinguish the individual medical relationship from a group education session: they answer different questions and need not occur on the same timetable. Ask how a new symptom reaches a clinician, whether a personal nutrition appointment costs extra and what happens if an in-person examination becomes necessary. The useful question is how the service handles your next problem, not how many support features appear on a sales page.

A named pharmacy network is a useful starting point

Belle lists pharmacy partners and explains that assignment depends on the prescription and the state where it is sent. That is more useful than a generic claim about domestic fulfillment, although a list does not tell you which facility will prepare your particular vial. I would request that name before the order is finalized and compare it with the dispensing label on arrival. Ask about all ingredients, storage directions and who handles a damaged shipment. A provider’s certification claim or a pharmacy’s registration does not turn a compounded preparation into an FDA-approved medicine; those are separate questions.

State coverage does not settle product access

The pharmacy page describes care for adults across all 50 states and Washington, D.C., while explicitly saying treatment choices and dispensing partners can vary by location. I would confirm the actual prescription option for the state where the consultation occurs before choosing a supply plan. An online application being available is only the beginning of the screening process. The clinician can decline or redirect care, and a pharmacy’s ability to serve a state may differ from another partner’s. Someone moving or traveling should raise that timing issue with the care team before arranging the next consultation or shipment.

Canceling renewal is different from returning medication

Belle’s terms allow subscription renewal unless canceled beforehand and exclude refunds on prescription or compounded products once shipped. They direct customers with an incorrect or defective delivery to contact support within seven days. I would save the renewal date and request cancellation confirmation rather than assume stopping an intake or missing a message stops the charge. A longer supply deserves an especially clear answer about unused amounts and future shipments. These details matter even when a pricing page says there are no contracts: an order already processed and a future subscription payment are different financial events. For more context, see our GLP-1 cancellation and refund guide.

Shipping estimates need a complete timeline

The product pages describe delivery or shipping in roughly three to five days after approval. That is an advertised estimate, not proof that treatment will begin a fixed number of days after clicking an application button. Ask whether the quoted interval includes review, pharmacy preparation and carrier transit. If you already have a prescriber, coordinate records and refill timing before ending the existing arrangement. Confirm what to do if the box is delayed, the label is unclear or the contents appear damaged; the appropriate response should come from the dispensing pharmacy or care team rather than a general delivery promise. For more context, see our care-transfer worksheet.

My assessment: useful transparency, with a payment question first

Belle stands out most for describing the people and pharmacies behind its offer and for including nutrition and nurse support in its advertised care model. My reservation is how easily a from-price can be mistaken for the amount due for one month. I would compare its written supply quote with another medication-inclusive program before committing, then judge whether the support actually fits the way I want to receive care. Strut Health offers another GLP-1 review path, while LifeMD is worth comparing if the care membership and insurance-related process are central to the decision. None is an automatic substitute for the prescription a clinician recommends. Compare the service details in our Strut Health review.

Before you sign up

• What supply length and upfront payment produce this advertised monthly rate?
• Which pharmacy and ingredients apply to my prescription?
• When does my subscription renew and what can be refunded before shipment?

Use the answers to compare the exact offer with another provider. A service review cannot determine whether a medication is appropriate for you; that decision belongs with your clinician.